Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies.

导出 OA

翻译打印收藏纠错

作者： Katarina,Nikolic ^[1] ; Lazaros,Mavridis ^[2] ; Teodora,Djikic ^[3] ; Jelica,Vucicevic ^[1] ; Danica,Agbaba ^[1] ; Kemal,Yelekci ^[3] ; John B O,Mitchell ^[4]

作者单位： Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade Belgrade, Serbia. ^[1] School of Biological and Chemical Sciences, Queen Mary University of London London, UK. ^[2] Department of Bioinformatics and Genetics, Faculty of Engineering and Natural Sciences, Kadir Has University Istanbul, Turkey. ^[3] EaStCHEM School of Chemistry and Biomedical Sciences Research Complex, University of St Andrews St Andrews, UK. ^[4]

关键词 CNS disease QSAR cheminformatic multi-target drugs rational drug design virtual docking virtual screening

DOI 10.3389/fnins.2016.00265

PMID 27375423

发布时间 2022-04-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览28

Frontiers in neuroscience

2016年10卷

265页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies.

Frontiers in neuroscience

相似文献

Frontiers in neuroscience

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies.

Frontiers in neuroscience

相似文献

Frontiers in neuroscience

相关期刊

检索历史清除